Apply for a Grant We provide awards primarily for translational and clinical research grants related to ataxia-telangiectasia.

Grant Length: One or Two Years

Grant Cost: Maximum total direct cost of $75,000 per year.

Descriptive text goes here… eveniet ut et voluptates repudiandae sint et molestiae nobis est eligendi optio cumque nihil impedit quo minus id quod maxime autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe .

How Grant Decisions Are Made A two-tiered, peer-review selection process

Descriptive text goes here… nobis est eligendi optio cumque nihil impedit quo minus id quod maxime nihil impedit quo minus id quod maxime placeatomnis dolor.

How To Apply

1. Review Guidelines

Short descriptive text goes here... ducimus qui blanditiis soluta nobis est eligend.

View Guidelines

2. Submit Letter of Intent

Short descriptive text goes here... ducimus qui blanditiis soluta nobis est eligend.

Download LOI Form

3. If Invited, Submit Proposal

Short descriptive text goes here... ducimus qui blanditiis soluta nobis est eligend.

Download Proposal Form

Need Help? Contact Us We welcome investigators to contact us if help is needed forming collaborations or obtaining reagents for A-T/ATM research.

Grant Application Grant Guidelines

Additional Resources

View All
  • View All
  • Clinical Studies and Trials
  • Researchers and Clinicians

Antibodies

Information on where to find commercially produced antibodies.


ATTeST

This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.


Automated Gait Analysis

Tools to measure the neurological problems in mice with ataxia-telangiectasia (A-T)


Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.


Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.


Brain and Tissue Bank

A-T brain tissue and other tissues may be available for research purposes.


Cell Bank

The A-TCP has established a program for the collection, submission and maintenance of cell lines from patients with A-T.


Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.


Dexamethasone Trial

This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.


Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.


Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.


IB1001 TRIAL

IntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.